EUVIMEDEUVIMED entdecken
Crossref

Metabolomics insights into the causal associations between antihypertensive drugs and myocarditis

Xinru Hu, Teng Hu, Yuyang Ye, Xuefeng Chen, Simayi Abulikemu, Jiang Yu, Yifei Zhao, Junwen Wang, Yong Peng

International Immunopharmacology · 2025-06 · 159 · 114946

DOI: 10.1016/j.intimp.2025.114946 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025-06. Verfasst von Xinru Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu 610041, China. Hauptthemen laut MEDLINE: Antihypertensive Agents, Myocarditis, Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Sichuan University, West China Hospital, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The role of various antihypertensive drug classes in myocarditis remains unclear. We aimed to investigate the causal effects of antihypertensive medications on myocarditis and identify potential metabolic pathways. METHODS: We extracted single-nucleotide polymorphisms for systolic blood pressure (SBP) and diastolic BP (DBP) from a genome-wide association study (N = 757,601) and screened single-nucleotide polymorphisms associated with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, β-blockers (BB), calcium channel blockers (CCB), and thiazides as instrumental variables. Summary-level statistics of myocarditis were sourced from the FinnGen study, encompassing 1847 cases and 231,952 controls. We subsequently performed a drug-targeted Mendelian randomization (MR) and a two-step network MR approach to investigate the causal impact of antihypertensive medications on myocarditis and to uncover metabolic mediators. RESULTS: Our study revealed that elevated SBP (odds ratio [OR] = 1.05, 95 % confidence interval [CI] = 1.04-1.06, p = 4.75 × 10-14) and DBP (OR = 1.07, 95 % CI = 1.05-1.10, p = 1.54 × 10-10) significantly increased myocarditis risk. Conversely, the use of BB (OR = 0.86, 95 % CI = 0.82-0.90, p = 5.14 × 10-10) and CCB (OR = 0.95, 95 % CI = 0.92-0.99, p = 0.005) to lower BP was associated with a reduced risk of myocarditis. Network MR analyses identified four and seven metabolites mediating BB and CCB associations with myocarditis, respectively. Methyl indole-3-acetate mediated a significant portion of the relationships between BB and myocarditis (mediation proportion = 6.82 %), while phenylalanine to tyrosine ratio was the predominant mediator (mediation proportion = 11.35 %) linking CCB to myocarditis. CONCLUSIONS: Our findings suggest that reducing BP through antihypertensive drugs, specifically BB and CCB, may hold potential for preventing myocarditis and have identified several metabolic pathways linking these associations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsMyocarditisHypertensionHumansPolymorphism, Single NucleotideMetabolomicsMendelian Randomization AnalysisBlood PressureGenome-Wide Association StudyMaleFemale

Stichwörter der Autor:innen

Antihypertensive drugsCirculating metabolitesMediationMendelian randomizationMyocarditis

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu 610041, China.
  • Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu 610041, China. Electronic address: pengyong@scu.edu.cn.

Förderung

  • Sichuan University
  • West China Hospital, Sichuan University

Zitieren

APA

Hu, X., Hu, T., Ye, Y., Chen, X., Abulikemu, S., Yu, J., Zhao, Y., Wang, J., & Peng, Y. (2025). Metabolomics insights into the causal associations between antihypertensive drugs and myocarditis. International Immunopharmacology, 159, 114946. https://doi.org/10.1016/j.intimp.2025.114946

Vancouver

Hu X, Hu T, Ye Y, Chen X, Abulikemu S, Yu J, et al. Metabolomics insights into the causal associations between antihypertensive drugs and myocarditis. International Immunopharmacology. 2025;159:114946. doi:10.1016/j.intimp.2025.114946

BibTeX
@article{Hu2025,
  author = {Hu, Xinru and Hu, Teng and Ye, Yuyang and Chen, Xuefeng and Abulikemu, Simayi and Yu, Jiang and Zhao, Yifei and Wang, Junwen and Peng, Yong},
  title = {Metabolomics insights into the causal associations between antihypertensive drugs and myocarditis},
  journal = {International Immunopharmacology},
  year = {2025},
  volume = {159},
  pages = {114946},
  doi = {10.1016/j.intimp.2025.114946}
}
Kostenlos starten →